591 related articles for article (PubMed ID: 30251463)
1. Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
Sirica AE; Gores GJ; Groopman JD; Selaru FM; Strazzabosco M; Wei Wang X; Zhu AX
Hepatology; 2019 Apr; 69(4):1803-1815. PubMed ID: 30251463
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis.
Rahnemai-Azar AA; Weisbrod A; Dillhoff M; Schmidt C; Pawlik TM
Surg Oncol; 2017 Jun; 26(2):125-137. PubMed ID: 28577718
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.
Sirica AE; Strazzabosco M; Cadamuro M
Adv Cancer Res; 2021; 149():321-387. PubMed ID: 33579427
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis, diagnosis, and management of cholangiocarcinoma.
Ilyas SI; Gores GJ
Gastroenterology; 2013 Dec; 145(6):1215-29. PubMed ID: 24140396
[TBL] [Abstract][Full Text] [Related]
5. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications.
Wu HJ; Chu PY
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450710
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic cholangiocarcinoma: current management and emerging therapies.
Rahnemai-Azar AA; Weisbrod AB; Dillhoff M; Schmidt C; Pawlik TM
Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):439-449. PubMed ID: 28317403
[TBL] [Abstract][Full Text] [Related]
7. Molecular Pathogenesis and Current Therapy in Intrahepatic Cholangiocarcinoma.
Høgdall D; O'Rourke CJ; Taranta A; Oliveira DV; Andersen JB
Dig Dis; 2016; 34(4):440-51. PubMed ID: 27170400
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for hepatobiliary cancers: Emerging targets and translational advances.
Li D; Lin S; Hong J; Ho M
Adv Cancer Res; 2022; 156():415-449. PubMed ID: 35961708
[TBL] [Abstract][Full Text] [Related]
10. Liver Transplantation for Intrahepatic Cholangiocarcinoma: Ready for Prime Time?
Sapisochin G; Ivanics T; Heimbach J
Hepatology; 2022 Feb; 75(2):455-472. PubMed ID: 34859465
[TBL] [Abstract][Full Text] [Related]
11. EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma.
;
J Hepatol; 2023 Jul; 79(1):181-208. PubMed ID: 37084797
[TBL] [Abstract][Full Text] [Related]
12. The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches.
Trifylli EM; Kriebardis AG; Koustas E; Papadopoulos N; Vasileiadi S; Fortis SP; Tzounakas VL; Anastasiadi AT; Sarantis P; Papageorgiou EG; Tsagarakis A; Aloizos G; Manolakopoulos S; Deutsch M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958547
[TBL] [Abstract][Full Text] [Related]
13. Matricellular proteins in intrahepatic cholangiocarcinoma.
Sirica AE
Adv Cancer Res; 2022; 156():249-281. PubMed ID: 35961702
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of intrahepatic cholangiocarcinoma.
Haga H; Patel T
J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):114-23. PubMed ID: 25267595
[TBL] [Abstract][Full Text] [Related]
15. Molecular Pathogenesis of Cholangiocarcinoma.
Labib PL; Goodchild G; Pereira SP
BMC Cancer; 2019 Feb; 19(1):185. PubMed ID: 30819129
[TBL] [Abstract][Full Text] [Related]
16. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
17. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of intrahepatic cholangiocarcinoma: the search for new therapeutic targets.
Oliveira DV; Zhang S; Chen X; Calvisi DF; Andersen JB
Expert Rev Gastroenterol Hepatol; 2017 Apr; 11(4):349-356. PubMed ID: 28162004
[TBL] [Abstract][Full Text] [Related]
19. Different iron-handling in inflamed small and large cholangiocytes and in small and large-duct type intrahepatic cholangiocarcinoma.
Mancinelli R; Cutone A; Rosa L; Lepanto MS; Onori P; Pannarale L; Franchitto A; Gaudio E; Valenti P
Eur J Histochem; 2020 Oct; 64(4):. PubMed ID: 33131269
[TBL] [Abstract][Full Text] [Related]
20. Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: a retrospective analysis of 156 cases in a single center.
Jesper D; Heyn SG; Schellhaas B; Pfeifer L; Goertz RS; Zopf S; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2018 May; 30(5):552-556. PubMed ID: 29280922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
